As COVID-19 is associated with pulmonary and vascular manifestations, we also investigated autoantibodies targeting myeloperoxidase (MPO), proteinase 3 (PR3) and glomerular basement membrane (GBM). The gene discussed is MPO; the disease is COVID-19.